I know that you are still confused about how Shivom - building the largest genomic and health data hub on the blockchain would help us in terms of medical attention. Here I will try to tell you more about Shivom and how could this be possible and useful in the blockchain, using the blockchain.
First, What is Genome/Genomic Medicine?
It is an emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., for diagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical use." Already, genomic medicine is making an impact in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious disease.
How the blockchain could help Genomic Medicine?
As you know, blockchain is a public ledger that could be seen by all people around the planet also, there is no third party could intervene on the transaction that is happening. Blockchain is just a program, open to all innovations to change and improve daily lives, and this is the opportunity taken by Shivom. Anonymously hiding the owners identity BUT showing it's health issues around the globe and the medication being made is a huge opportunity and open to innovations healthcare that Shivom wanted to promote. ( See whitepaper for more detailed information of infographic charts )
These are the things that Shivom wants to happen
- Everybody will be able to get their genome sequenced and securely stored, and our ecosystem will offer an open web-marketplace for providers to add their apps and services alongside advanced data analytics. The SHIVOM platform works on principles of collaboration and integrity, allowing people to own, manage and monetize their genomics and health data. As we build this global healthcare ecosystem, we will reach even underserved and low-income countries where such services have not been previously available.
- The solution will create shared value for individuals, not-for-profit organizations, governments, and for-profit entities alike.
- Have partnered with the top developers and healthcare organizations, and technology companies and big pharma are already lining up to take advantage of our unique genomics and healthcare approach. As Shivom scales up and goes global, we have many more partnerships already in development.
- The platform is truly pioneering in the way it utilizes blockchain technology, to protect, secure and monetize the donor’s DNA data to drive precision medicine and healthcare forward.
To make those things possible for the project's development, they are currently conducting an ICO/crowdfunding that would let people to invest and be a part of Shivom's success.
Here are some information's about their Token Sale.
The Goal
Durning the ICO, they are having cap's that would determine on how much they would want to raise and on how much would they sell their tokens.
Softcap: 15,000 ETH
Hardcap: 75,000 ETH
Price: 7,000 OMX / ETH
Pre-sale: 16th April — 22nd April (pre-sale terms not yet officially released)
Public sale: Not officially released
Token distribution
• 3 billion tokens to be distributed
• 90M OmiX to the community
• 420M OmiX to founders
• 300M OmiX to advisors
• 600M OmiX for Incentivizing Growth Pool
• 600M OmiX to Company Reserve
*** Number of OmiX tokens at ICO not stated however appears to be 990M MAX ***
Having the transparent crowdfunding visible to all using the blockchain, the proceeds of the ICO would go to ....
ICO funds distribution nominated as being:
• 20% — platform development
• 11% — operations and business development
• 10% — non profit R&D
• 21% — partnerships and marketing
• 5% — legal
• 2% — proof of concept
• 6% — data storage
• 25% — laboratories
*** Founder and advisor tokens are locked for between 18 months and 3 years dependant upon their involvement in the project and stage of entry into the company. ***
The OmiX token enables buying, trading, incentivizing and other services. The token is the fuel of the Shivom ecosystem, as well as part of the governance of the system. Tokens offer the following:
• Ability to acquire premium services in the Shivom ecosystem
• Ability to acquire genome sequencing kits
• Ability to sponsor sequencing projects
• Ability to acquire access to health/fitness apps from 3rd party providers
• Ability to access the genome database
• Ability to pay donors for data/participation in research studies
• Ability for service providers to use the platform
The Catch
The OmiX token enables buying, trading, incentivizing and other services. The token is the fuel of the Shivom ecosystem, as well as part of the governance of the system. Tokens offer the following:
• Ability to acquire premium services in the Shivom ecosystem
• Ability to acquire genome sequencing kits
• Ability to sponsor sequencing projects
• Ability to acquire access to health/fitness apps from 3rd party providers
• Ability to access the genome database
• Ability to pay donors for data/participation in research studies
• Ability for service providers to use the platform
Pro's
• A potentially large market given world population however I’m not sure that too many care enough about genome sequencing for this market size to be realised. The team are however aware of this and research shows one of the biggest barriers for people when considering genomic testing is the security of their data. The blockchain solution offered by Shivom should resolve this problem.
• Recent partnership announced with Genetic Technologies Ltd (GTG), which is a publicly listed Australian company providing a clinically validated risk assessment test for non-hereditary breast cancer. This partnership provides Shivom with access to GTG’s accredited laboratory in Victoria, Australia. GTG will also become part of Shivom’s global genetic counselling network and obtain access to Shivom’s pool of genomic data. This also extends to GTG accredited facilities in the US.
• Recent MoU signed with the Government of Andhra Pradesh, which ‘explores the possibility of providing diagnostic services to patients of Andhra Pradesh by maintaining the privacy of the individual data through blockchain technologies’. It will also focus on shifting from using genomic data for research to using this data for predictive healthcare in a preventative approach. A part of this deal gives Shivom access to conduct pilot testing in the Andhra Pradesh cancer research centre working direct with government.
• A partnership with DeHedge in which Shivom will be the first token offered as a hedged token on their platform. This protects contributors (to some degree) from volatility and risk. The DeHedge team also stringently vet projects before accepting them onto their platform so this also offers some degree of certainty and trust in the Shivom project.
• Strategic technical partnerships with Ocean Protocol and Spherity Protocol.
Con's
• The majority of team members have at least one other project running concurrent to Shivom. Per Lind is particularly concerning with his LinkedIn profile listing involvement in a further 10 projects (including IOTA) from co-founder to partner, VP and director of these other organisations.
• 990M tokens available for ICO yet 600M are allocated for ‘incentives’ and another 600M for ‘company reserves’. In my opinion these numbers seem too high and I feel the incentives (bounty programs mentioned) will dilute the value of the tokens sold during ICO.
Hope that this article could help you determine whether this is a good project to invest on or not. To know more of them you could visit these links below.
Website : https://shivom.io/
Telegram : https://t.me/projshivom
Facebook : https://www.facebook.com/ProjectShivom
Twitter : https://twitter.com/projectshivom
Instagram : https://www.instagram.com/projectshivom
Reddit : https://www.reddit.com/r/Shivom/
Youtube Channel : https://www.youtube.com/c/ProjectShivom
Bitcointalk : https://bitcointalk.org/index.php?topic=2365709.msg24124494#msg24124494
CREATOR
aervin11
https://bitcointalk.org/index.php?action=profile;u=1196880
No comments:
Post a Comment